AL
SUPN icon

AJO LP’s Supernus Pharmaceuticals SUPN Stock Holding History

AJO LP’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-149,430
Closed -$3.11M – 613
2020
Q3 		$3.11M Buy
149,430
+3,705
+3% +$84.1K 0.03% 329
2020
Q2 		$3.46M Buy
145,725
+24,037
+20% +$531K 0.03% 312
2020
Q1 		$2.19M Sell
121,688
-39,625
-25% -$833K 0.02% 333
2019
Q4 		$3.83M Buy
161,313
+90,567
+128% +$2.2M 0.02% 317
2019
Q3 		$1.94M Sell
70,746
-19,776
-22% -$586K 0.01% 400
2019
Q2 		$3M Buy
90,522
+6,286
+7% +$215K 0.02% 366
2019
Q1 		$2.95M Buy
+84,236
New +$3.13M 0.02% 407
2018
Q4 		– Sell
-7,251
Closed -$365K – 712
2018
Q3 		$365K Buy
7,251
+158
+2% +$7.8K ﹤0.01% 590
2018
Q2 		$425K Buy
+7,093
New +$367K ﹤0.01% 590

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return

AJO LP's SUPN Position: Q4 2020 in Review

AJO LP sold out of Supernus Pharmaceuticals (SUPN) in Q4 2020, closing a stake of 149,430 shares — an estimated $3.11M sold.

AJO LP first reported a position in SUPN in Q2 2018 and held it in 9 quarters. The position peaked at $3.83M in Q4 2019. 225 funds tracked by Wall St. Rank hold SUPN as of Q4 2020.

  • AJO LP reported no remaining Supernus Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • AJO LP sold 149,430 Supernus Pharmaceuticals shares in Q4 2020, an estimated $3.11M.
  • AJO LP first reported a position in Supernus Pharmaceuticals in Q2 2018 and held it in 9 quarters.
  • AJO LP's Supernus Pharmaceuticals position peaked at $3.83M in Q4 2019.
  • 225 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2020.

Based on AJO LP's 13F filing for Q4 2020, filed 5 Feb 2021.